Cargando…

Ethics, human rights and programmatic management of drug-resistant tuberculosis

Detalles Bibliográficos
Autor principal:	Dholakia, Yatin N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276055/ https://www.ncbi.nlm.nih.gov/pubmed/22345934 http://dx.doi.org/10.4103/0970-2113.92384

Ejemplares similares

Guidelines for the programmatic management of drug-resistant tuberculosis emergency update 2008.
Publicado: (2008)

Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda
por: Mitnick, Carole D., et al.
Publicado: (2016)

Drug-resistant tuberculosis: Study of clinical practices of chest physicians, Maharashtra, India
por: Dholakia, Yatin, et al.
Publicado: (2012)

Clinical profile and treatment outcomes of drug-resistant tuberculosis before directly observed treatment strategy plus: Lessons for the program
por: Dholakia, Yatin N., et al.
Publicado: (2013)

Programmatic Challenges in Managing Multidrug-Resistant Tuberculosis in Malawi
por: Charlie, Loveness, et al.
Publicado: (2021)

Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda
por: Cobelens, Frank G. J, et al.
Publicado: (2008)

ETHICS BETWEEN INDIVIDUAL RIGHTS AND SOCIAL RESPONSIBILITIES
por: Giwa, Al O., et al.
Publicado: (2023)

Diabetes mellitus and tuberculosis: programmatic management issues
por: Harries, A. D., et al.
Publicado: (2015)

Mycobacterium tuberculosis Drug Resistance, Ghana
por: Owusu-Dabo, Ellis, et al.
Publicado: (2006)

Does physicians’ right to strike outweigh students’ right to an education? The on-going ethical dilemma in Peru
por: Carrillo-Larco, Rodrigo M., et al.
Publicado: (2012)

Pathway to care for drug resistant tuberculosis cases identified during a retrospective study conducted in high TB burden wards in Mumbai
por: Lobo, Eunice, et al.
Publicado: (2018)

Extensively Drug-Resistant Tuberculosis, China
por: Tang, Shenjie, et al.
Publicado: (2011)

Extensively Drug-Resistant Tuberculosis,Taiwan
por: Yu, Ming-Chih, et al.
Publicado: (2008)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

Spread of Extensively Drug-resistant Tuberculosis
por: Samper, Sofía, et al.
Publicado: (2007)

Mycobacterium tuberculosis Drug Resistance, Abkhazia
por: Pardini, Manuela, et al.
Publicado: (2005)

Drug-resistant Mycobacterium tuberculosis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2006)

Permanent dialysis catheter-related right atrial mass: A case report
por: Singh, Ajmer, et al.
Publicado: (2020)

Programmatically Selected Multidrug-Resistant Strains Drive the Emergence of Extensively Drug-Resistant Tuberculosis in South Africa
por: Müller, Borna, et al.
Publicado: (2013)

Extensively Drug-Resistant Mycobacterium tuberculosis, India
por: Mondal, Rajesh, et al.
Publicado: (2007)

Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004)

Extensively Drug-resistant Tuberculosis, Italy and Germany
por: Migliori, Giovanni Battista, et al.
Publicado: (2007)

Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands
por: de Vries, Gerard, et al.
Publicado: (2017)

Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2021)

Drug-Resistant Mycobacterium tuberculosis among New Tuberculosis Patients, Yangon, Myanmar
por: Phyu, Sabai, et al.
Publicado: (2003)

Prevalence of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Patients with Pulmonary Tuberculosis in Zahedan, Southeastern Iran
por: Metanat, M, et al.
Publicado: (2012)

Skin snips have no role in programmatic evaluations for onchocerciasis elimination: a reply to Bottomley et al.
por: Eberhard, Mark L., et al.
Publicado: (2017)

COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho
por: Andom, Afom T., et al.
Publicado: (2023)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
por: Achar, Jay, et al.
Publicado: (2015)

Beijing genotype of Mycobacterium tuberculosis is associated with extensively drug-resistant tuberculosis: A global analysis
por: Keikha, M., et al.
Publicado: (2021)

Clinical practice of chest physicians for treatment of drug-resistant tuberculosis
por: De, Sajal
Publicado: (2012)

Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
por: Winston, Carla A., et al.
Publicado: (2012)

Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009
por: Shi, Dawei, et al.
Publicado: (2012)

Drug-resistant tuberculosis: Response to More et al. (2017)
por: Basu, Saurav
Publicado: (2017)

Living and dying with drug resistant tuberculosis - Are we doing enough?
por: Mehta, Vibha, et al.
Publicado: (2020)

Airway management: High flow nasal oxygenation
por: Kumar, Ajay, et al.
Publicado: (2016)

Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis
por: Deoghare, Shashank
Publicado: (2013)

Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
por: Aggarwal, Anivita, et al.
Publicado: (2020)

Airway management: Few more lessons to learn
por: Roy, Preety M., et al.
Publicado: (2016)

Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us
por: Bhattacharya Chakravarty, Aruna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_u4j44h7523irsu9pal9k5jgf2l